查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1775447

全球乳房攝影影像市場：2025-2030 年預測

Global Breast Imaging Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計乳房攝影影像市場規模將從 2025 年的 50.75 億美元成長至 2030 年的 73.94 億美元，複合年成長率為 7.82%。

提高乳癌發生率和認知度

世界衛生組織 (WHO) 指出，乳癌仍然是全球女性最常見的癌症之一，已開發國家和開發中國家均受影響。乳癌存活率低的主要原因是早期發現計畫不足以及缺乏定期篩檢的意識，導致患者確診時已是晚期。隨著乳癌發生率的上升，女性越來越意識到及時篩檢的重要性，透過早期發現可以顯著降低患病風險。這些變化推動了對先進乳房攝影影像設備的需求，並刺激了市場擴張，因為醫療保健提供者優先考慮能夠提高診斷準確性和患者預後的技術。

採用先進的影像診斷技術

市場受益於創新乳房攝影方式的採用，這些方式提高了診斷效率。分子乳房攝影(MBI)、造影乳房X光攝影(CEM)、正子乳房 X 光乳房X光攝影(PEM)、電電阻測試 (EIT) 和光學影像檢查等技術正變得越來越普遍。 MBI 是一種核醫學方法，涉及注射化學示踪劑和使用專門的相機來評估乳房異常，特別是對於乳房緻密或乳房乳房X光攝影異常的女性。 CEM 使用碘基顯影劑來突出顯示異常乳房組織，是 MRI 的一種經濟有效的替代方案。 PEM 與 PET 類似，使用放射性糖來檢測小簇癌細胞。 EIT 利用癌細胞和正常細胞之間的電導率差異，而光學成像則分析光透射以監測癌症生長。儘管存在 MBI 和 PEM 中的輻射暴露等挑戰，但這些方法透過實現更精確的診斷促進了市場發展。

技術進步

乳房攝影成像技術的不斷創新是主要促進因素。先進的系統正在開發中，其檢測和監測癌細胞擴散的能力得到了提升，從而提高了診斷準確性和工作流程效率。隨著製造商推出多樣化、高效能的影像解決方案，這些進步預計將在醫療保健領域得到更廣泛的應用。由於醫療保健提供者努力滿足對早期有效乳癌檢測日益成長的需求，對能夠提供更快、更準確結果的先進設備的關注預計將在預測期內推動市場成長。

市場挑戰

儘管技術不斷進步，但某些影像技術（例如MBI和PEM）仍涉及輻射暴露，限制了其在常規篩檢中的應用。新興方法（例如EIT和光學成像）需要進一步的臨床檢驗和基礎設施投資，這為其廣泛應用帶來了障礙。這些挑戰凸顯了持續研究的必要性，以平衡診斷效果與病人安全性和可近性。

區域展望

由於乳癌的高發病率和不斷上升的死亡率，預計北美將在整個預測期內佔據主導市場佔有率，這推動了對先進診斷影像解決方案的投資和宣傳宣傳活動。在加強診斷設施和醫療保健基礎設施的努力下，亞太地區預計將擴大市場佔有率。這些區域趨勢反映了不同的醫療保健重點和投資，從而塑造了市場的成長軌跡。

結論

受乳癌患者數量成長、早期檢測意識增強以及創新影像技術推動，乳房攝影影像市場正呈現強勁成長勢頭。北美憑藉其高發病率和投資額度，佔據市場領先地位；而亞太地區則有望透過改善診斷基礎設施來實現成長。儘管存在輻射風險和實施障礙等挑戰，但MBI、CEM、PEM、EIT、光學成像等領域的進步正在拓展市場機會。產業專家應注意到，技術創新和區域動態在塑造市場未來發展中發揮關鍵作用。

本報告的主要優點

  • 深刻分析：獲得涵蓋主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場。
  • 競爭格局：了解全球主要企業採取的策略策略，並了解正確策略帶來的潛在市場滲透。
  • 市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
  • 可行的建議：利用洞察力進行策略決策，在動態環境中開闢新的業務流和收益。
  • 適用範圍廣：對於新興企業、科學研究機構、顧問公司、中小企業、大型企業都有利且划算。

它有什麼用途？

產業與市場考量、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

研究範圍

  • 2022 年至 2024 年的歷史數據和 2025 年至 2030 年的預測數據
  • 成長機會、挑戰、供應鏈前景、法律規範與趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 收益成長和預測包括國家在內的細分市場和地區分析
  • 公司概況（特別是財務狀況和關鍵發展）

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 研究範圍
  • 市場區隔

第3章 商業景氣

  • 市場促進因素
  • 市場限制
  • 市場機會
  • 波特五力分析
  • 產業價值鏈分析
  • 政策法規
  • 策略建議

第4章 技術展望

第5章乳房攝影影像市場（按技術）

  • 介紹
  • 乳房X光檢查
  • 超音波
  • 磁振造影（MRI）
  • 核子造影
  • 其他

第6章乳房攝影影像市場（依程序）

  • 介紹
  • 乳房X篩檢
  • 診斷性乳房X光檢查
  • 乳房斷層合成
  • 乳腺超音波
  • 乳房MRI
  • 其他

第7章乳房攝影診斷市場（按最終用戶）

  • 介紹
  • 醫院
  • 診斷中心
  • 研究部門

第8章乳房攝影診斷市場（按區域）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 其他

第9章競爭格局及分析

  • 主要企業和策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭儀錶板

第10章 公司簡介

  • GE Healthcare
  • Hologic, Inc.
  • Siemens Healthineers AG
  • Koninklijke Philips NV
  • Fujifilm Holdings Corporation
  • Canon Medical Systems Corporation
  • Dilon Technologies, Inc.

第11章 附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061613457

The Global Breast Imaging Market is expected to grow from USD 5.075 billion in 2025 to USD 7.394 billion in 2030, at a CAGR of 7.82%.

Increasing Breast Cancer Incidence and Awareness

Breast cancer remains one of the most prevalent cancers affecting women globally, as noted by the World Health Organization, with significant impact in both developed and developing nations. Low survival rates are primarily due to inadequate early detection programs and limited awareness of routine screenings, leading to late-stage diagnoses. The growing incidence of breast cancer is driving heightened awareness among women about the importance of timely checkups, which significantly reduce risks through early detection. This shift is increasing demand for advanced breast imaging equipment, fueling market expansion as healthcare providers prioritize technologies that enhance diagnostic accuracy and patient outcomes.

Adoption of Advanced Imaging Techniques

The market is benefiting from the adoption of innovative breast imaging methods that improve diagnostic efficiency. Techniques such as molecular breast imaging (MBI), contrast-enhanced mammography (CEM), positron emission mammography (PEM), electrical impedance testing (EIT), and optical imaging tests are gaining traction. MBI, a nuclear medicine approach, involves injecting a chemical tracer and using a specialized camera to evaluate breast abnormalities, particularly for women with dense breasts or abnormal mammograms. CEM uses iodine-based contrast dye to highlight abnormal breast tissue, offering a cost-effective alternative to MRI. PEM, akin to PET scans, employs radioactive sugar to detect small cancer cell clusters. EIT leverages differences in electrical conductivity between cancerous and normal cells, while optical imaging analyzes light transmission to monitor cancer growth. These methods, despite challenges like radiation exposure in MBI and PEM, are driving the development of enhanced imaging equipment, contributing to market growth by enabling more precise diagnostics.

Technological Advancements

Continuous innovation in breast imaging technologies is a key growth driver. Advanced systems with improved capabilities for detecting and monitoring cancer cell spread are being developed, enhancing diagnostic precision and workflow efficiency. These advancements are expected to increase adoption across healthcare settings, as manufacturers introduce diverse, high-performance imaging solutions. The focus on sophisticated equipment that delivers faster, more accurate results is anticipated to propel market growth over the forecast period, as providers seek to meet rising demand for early and effective breast cancer detection.

Market Challenges

Despite technological progress, certain imaging techniques, such as MBI and PEM, involve radiation exposure, limiting their use in routine screening. Emerging methods like EIT and optical imaging require further clinical validation and infrastructure investment, posing barriers to widespread adoption. These challenges highlight the need for ongoing research to balance diagnostic efficacy with patient safety and accessibility.

Regional Outlook

North America is expected to maintain a dominant market share through the forecast period, driven by the high prevalence of breast cancer and increasing mortality rates, which are prompting greater investment in advanced imaging solutions and awareness campaigns. The Asia Pacific region is poised to expand its market share, supported by initiatives to enhance diagnostic facilities and healthcare infrastructure. These regional trends reflect varying healthcare priorities and investments, shaping the market's growth trajectory.

Conclusion

The breast imaging market is on a strong growth path, driven by rising breast cancer cases, growing awareness of early detection, and innovative imaging technologies. North America leads due to high disease prevalence and investment, while Asia Pacific is set to grow through improved diagnostic infrastructure. Despite challenges like radiation risks and adoption barriers, advancements in MBI, CEM, PEM, EIT, and optical imaging are expanding market opportunities. Industry experts should note the critical role of technological innovation and regional dynamics in shaping the market's future.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

By Technology

  • Mammography
  • Ultrasound
  • Magnetic Resonance Imaging (MRI)
  • Nuclear Imaging
  • Others

By Procedure

  • Screening Mammography
  • Diagnostic Mammography
  • Breast Tomosynthesis
  • Breast Ultrasound
  • Breast MRI
  • Others

By End-User

  • Hospitals
  • Diagnostic Centers
  • Research Laboratories

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Others
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. BREAST IMAGING MARKET BY TECHNOLOGY

  • 5.1. Introduction
  • 5.2. Mammography
  • 5.3. Ultrasound
  • 5.4. Magnetic Resonance Imaging (MRI)
  • 5.5. Nuclear Imaging
  • 5.6. Others

6. BREAST IMAGING MARKET BY PROCEDURE

  • 6.1. Introduction
  • 6.2. Screening Mammography
  • 6.3. Diagnostic Mammography
  • 6.4. Breast Tomosynthesis
  • 6.5. Breast Ultrasound
  • 6.6. Breast MRI
  • 6.7. Others

7. BREAST IMAGING MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Diagnostic Centers
  • 7.4. Research Laboratories

8. BREAST IMAGING MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Israel
    • 8.5.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Australia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. GE Healthcare
  • 10.2. Hologic, Inc.
  • 10.3. Siemens Healthineers AG
  • 10.4. Koninklijke Philips N.V.
  • 10.5. Fujifilm Holdings Corporation
  • 10.6. Canon Medical Systems Corporation
  • 10.7. Dilon Technologies, Inc.

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations